trending Market Intelligence /marketintelligence/en/news-insights/trending/_W4dU0_YxQJOXBbguGyx2g2 content esgSubNav
In This List

Diagnostics company Natera names CEO, COO

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Diagnostics company Natera names CEO, COO

Natera Inc. appointed Steve Chapman as CEO and Robert Schueren as COO, effective Jan. 2 and Jan. 7, respectively.

Chapman, who was previously the company's COO, will succeed Matthew Rabinowitz, who is the co-founder and CEO of Natera.

Meanwhile, Rabinowitz will remain involved as executive chairman.

Schueren has served in executive leadership roles at companies including Genentech Inc., Agilent Technologies Inc. and IntegenX Inc., which was recently acquired by Thermo Fisher Scientific Inc.

San Carlos, Calif.-based Natera is a diagnostics company, which provides preconception and prenatal genetic testing services. It mainly offers a non-invasive prenatal test called Panorama, which screens for chromosomal abnormalities of a fetus with blood drawn from the mother.